Skip to main content
. Author manuscript; available in PMC: 2021 Jun 23.
Published in final edited form as: Sci Immunol. 2020 Nov 6;5(53):eabb9726. doi: 10.1126/sciimmunol.abb9726

Table I.

Studies examining modulation of Wnt signaling and Tcf1.

T subsets Experimental Models Perturbations Findings Ref
Murine Th1 In vitro Tcf7 germline KO Tcf1 represses IFNγ 25
Murine Th1/Tfh LCMV Tcf7 long isoforms KO Tcf1 required for T memory formation 9
Murine Th17 In vitro, EAE Tcf7 germline KO Tcf1 represses IL17a 28, 29
Murine Th17 Colitis, colorectal cancer Constitutively active β-catenin Tcf1 binds Rorc locus in chromatin accessible regions 30
Murine Thymocytes T cell development Tcf7 germline KO, constitutively active β-catenin Tcf1 promotes thymocyte survival via enhancement of Rorγt 31
Human Th17 In vitro Wnt inhibitors Enhanced Th17 differentiation 32
Human Th17 In vitro Wnt3a, Wnt5a stimulation Reduced Th17 differentiation 32
Murine Tregs In vivo T cell development Tcf7 hemizygous Higher Treg percentage 44
Human and murine Tregs In vitro None Tcf1 interacts with and inhibits Foxp3-mediated transcription 45
Human and murine Tregs In vitro Gsk3β inhibitor, Wnt3a stimulation Reduced Treg suppressive capacity 45
Murine Tregs In vivo steady state Constitutively active β-catenin Spontaneous colitis 30
Murine Tregs In vivo steady state Treg-specific Tcf1/Lef1 double KO Spontaneous multi-organ autoimmunity 46,47